首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Gut microbes

缩写:

ISSN:1949-0976

e-ISSN:1949-0984

IF/分区:11.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2294
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
F Christopher Peritore-Galve,Izumi Kaji,Anna Smith et al. F Christopher Peritore-Galve et al.
Background & aim: Clostridioides difficile infection (CDI) is the leading cause of hospital-acquired diarrhea and pseudomembranous colitis. Two protein toxins, TcdA and TcdB, produced by C. difficile are the major determi...
Gang Fan,Feng Cao,Tingting Kuang et al. Gang Fan et al.
Although changes in gut microbiome have been associated with the development of T2D and its complications, the role of the gut virome remains largely unknown. Here, we characterized the gut virome alterations in T2D and its complications di...
Meixia Li,Yeqing Wang,Ciliang Guo et al. Meixia Li et al.
A demonstration of cellulose degrading bacterium from human gut changed our view that human cannot degrade the cellulose. However, investigation of cellulose degradation by human gut microbiota on molecular level has not been completed so f...
Yuqiu Han,Qi Ling,Li Wu et al. Yuqiu Han et al.
Current evidence indicates that the next-generation probiotic Akkermansia muciniphila (A. muciniphila) has therapeutic potential for nonalcoholic fatty liver disease (NAFLD), especially its inflammatory stage known as nonalcoholic steatohep...
Ana María Gómez-Pérez,Patricia Ruiz-Limón,Jordi Salas-Salvadó et al. Ana María Gómez-Pérez et al.
To evaluate the changes in the gut microbiota associated with changes in the biochemical markers of nonalcoholic fatty liver disease (NAFLD) after a lifestyle intervention with the Mediterranean diet. Participants (n = 297) from two centers...
Oshrit Shtossel,Haim Isakov,Sondra Turjeman et al. Oshrit Shtossel et al.
The human gut microbiome is associated with a large number of disease etiologies. As such, it is a natural candidate for machine-learning-based biomarker development for multiple diseases and conditions. The microbiome is often analyzed usi...
Rasel Barua,Paul Pavli,David M Gordon et al. Rasel Barua et al.
Escherichia coli (E. coli) is an important commensal in the human gut; however, it is unknown whether strains show site-specificity in the lower gut. To investigate this, we assessed genotypic and phenotypic differences in 37 clone pairs (t...
Jie Hu,Yifan Wu,Xingjian Zhou et al. Jie Hu et al.
The pathogenicity of Escherichia coli (E. coli) O157:H7 is predominantly associated with Shiga toxin 2 (Stx2) that poses a huge threat to human and animal intestinal health. Production of Stx2 requires expression of stx2 gene, which is loca...
Anne J Gonzales-Luna,Travis J Carlson,Kevin W Garey Anne J Gonzales-Luna
Human gut microbiota are critical to both the development of and recovery from Clostridioides difficile infection (CDI). Antibiotics are the mainstay of CDI treatment, yet inherently cause further imbalances in the gut microbiota, termed dy...
Daniela Stols-Gonçalves,Anne Linde Mak,Mette S Madsen et al. Daniela Stols-Gonçalves et al.
Individuals with nonalcoholic fatty liver disease (NAFLD) have an altered gut microbiota composition. Moreover, hepatic DNA methylation may be altered in the state of NAFLD. Using a fecal microbiota transplantation (FMT) intervention, we ai...